Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
  • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
  • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
  • A61M25/0026—Multi-lumen catheters with stationary elements
  • A61M25/003—Multi-lumen catheters with stationary elements characterized by features relating to least one lumen located at the distal part of the catheter, e.g. filters, plugs or valves
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
  • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
  • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
  • A61M25/0075—Valve means
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/09—Guide wires
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
  • A61M25/1011—Multiple balloon catheters
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
  • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
  • A61M25/0075—Valve means
  • A61M2025/0076—Unidirectional valves
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
  • A61M25/0074—Dynamic characteristics of the catheter tip, e.g. openable, closable, expandable or deformable
  • A61M2025/0079—Separate user-activated means, e.g. guidewires, guide tubes, balloon catheters or sheaths, for sealing off an orifice, e.g. a lumen or side holes, of a catheter
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/06—Body-piercing guide needles or the like
  • A61M25/0662—Guide tubes
  • A61M2025/0681—Systems with catheter and outer tubing, e.g. sheath, sleeve or guide tube
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/09—Guide wires
  • A61M2025/09058—Basic structures of guide wires
  • A61M2025/09075—Basic structures of guide wires having a core without a coil possibly combined with a sheath
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/09—Guide wires
  • A61M2025/09133—Guide wires having specific material compositions or coatings; Materials with specific mechanical behaviours, e.g. stiffness, strength to transmit torque
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
  • A61M2025/1043—Balloon catheters with special features or adapted for special applications
  • A61M2025/105—Balloon catheters with special features or adapted for special applications having a balloon suitable for drug delivery, e.g. by using holes for delivery, drug coating or membranes
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/10—Balloon catheters
  • A61M2025/1043—Balloon catheters with special features or adapted for special applications
  • A61M2025/1052—Balloon catheters with special features or adapted for special applications for temporarily occluding a vessel for isolating a sector
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0021—Catheters; Hollow probes characterised by the form of the tubing
  • A61M25/0023—Catheters; Hollow probes characterised by the form of the tubing by the form of the lumen, e.g. cross-section, variable diameter
  • A61M25/0026—Multi-lumen catheters with stationary elements
  • A61M25/0032—Multi-lumen catheters with stationary elements characterized by at least one unconventionally shaped lumen, e.g. polygons, ellipsoids, wedges or shapes comprising concave and convex parts
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/0067—Catheters; Hollow probes characterised by the distal end, e.g. tips
  • A61M25/0068—Static characteristics of the catheter tip, e.g. shape, atraumatic tip, curved tip or tip structure
  • A61M25/007—Side holes, e.g. their profiles or arrangements; Provisions to keep side holes unblocked
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
  • A61M25/0108—Steering means as part of the catheter or advancing means; Markers for positioning using radio-opaque or ultrasound markers
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
  • A61M25/00—Catheters; Hollow probes
  • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
  • A61M25/0105—Steering means as part of the catheter or advancing means; Markers for positioning
  • A61M25/0127—Magnetic means; Magnetic markers

Definitions

• exemplary procedural elements may include the following: obtaining a clear image of the vasculature including a vessel obstruction, lesion, or other treatment site using fluoroscopy and injection of contrast imaging agents through the lumen of a guide catheter or sheath before, during, and/or after treatment; accessing and crossing the vessel obstruction or lesion using a combination of one or more guide wires, guide catheters, support catheters, and/or sheaths; and finally treatment of the obstruction or lesion using specialized catheter-based tools (e.g., one or more angioplasty balloons, stent and stent delivery systems, atherectomy, drug delivery infusion catheters, and the like).
• specialized catheter-based tools e.g., one or more angioplasty balloons, stent and stent delivery systems, atherectomy, drug delivery infusion catheters, and the like.
• iodinated contrast agents act by attenuating the signal of an X-ray passed through the body of the patient, and manifest as a darker area on the resulting radiograph.
• Iodinated contrast agents are available in either ionic (e.g., Hypaque 50, Isopaque 370, Hexabrix, etc.) or non-ionic (e.g., Isovue 370, Omnipaque 350, Ultravist 370, etc.) forms, and are commonly used due to their solubility and relatively benign interaction with the body.
• the position of the balloon is then confirmed by injecting a contrast agent through the guide catheter or sheath to provide an angiographic image prior to the surgical or endovascular treatment.
• the obstruction is dilated by inflation of the balloon to restore blood flow, and the final result is confirmed using conventional angiography.
• the devices are removed from the patient.
• the relatively long distance between the source of contrast administration and the treatment site e.g., from the iliac to an arterial location below the knee
• a higher concentration and/or a larger volume of contrast agent coupled with a longer X-ray exposure time due to the longer run off time to obtain images that are of sufficiently high quality to aid in diagnosis and treatment.
• the use of a higher volume of contrast agent can induce nephropathy (i.e., contrast agent-induced damage to the kidneys), which is especially relevant to a large cohort of the patient population that suffers from peripheral vascular disease (e.g., diabetics).
• nephropathy i.e., contrast agent-induced damage to the kidneys
• peripheral vascular disease e.g., diabetics
• the high, prolonged doses of radiation associated with these techniques are not beneficial and can be harmful to the patient and/or the treating physician and staff. In some cases, it is not possible to acquire images of high enough quality to complete the intervention or treatment.
• this technique is restricted in that the guide catheter or sheath must have a large enough lumen to facilitate injection of a sufficient enough volume contrast agent at a desirable flow rate while the interventional equipment or treatment devices are indwelling within the lumen of the guide catheter or sheath.
• the larger size and/or rigidity of the guide catheter or sheath may also prohibit placement close to the smaller peripheral vasculature as desired for selective angiography.
• Another technique for treating peripheral vascular disease in arteries that are below the knee is to introduce the treatment device directly into an artery distal to the lesion and/or occlusion (e.g., introducing the treatment catheter via percutaneous trans-pedal access without an access sheath to treat a lesion in the calf) when lesion access from the antegrade approach is unsuccessful or prohibited. While this approach provides an alternative to the use of a larger or higher profile guide catheter or sheath used in the antegrade approach, the trans-pedal approach introduces several drawbacks. First, the contrast agent may not be easily injected through the treatment device, as described previously, inhibiting effective imaging of the treatment area.
• the small luminal diameter access sheath precludes the ability to inject adequate volumes of contrast agent and to obtain the high quality angiographic images necessary for diagnosis and treatment especially when interventional tools or treatment devices are placed within it. It is also noted that in cases of total occlusion, the absence of flow through the obstruction in the treatment artery would prevent imaging of the vasculature distal of the obstruction, thus the physician is essentially navigating blind until the lesion is crossed and confirmation of the location of the treatment catheter is obtained.
• a support catheter comprising a low profile, single or multiple lumen tube with a tapered tip.
• the support catheter is coaxially positioned over the guide wire to substantially augment the pushability over that of the guide wire alone and to increase the opportunity to successfully advance and position the guide wire across or within the obstruction.
• the guide wire may be exchanged with another type of guide wire (i.e., with a softer atraumatic wire), and then the support catheter may be removed from the patient while carefully maintaining the position of the guide wire across or within the obstruction.
• the treatment device may then be advanced along the guide wire to complete the procedure.
• the device of the first embodiment is advanced over the guide wire and into the patient.
• the operator may use the manifold to inject contrast through the fluid delivery lumen to obtain an angiogram of the anatomy distal to the lesion, and use the one or more images obtained to place the guide wire across the lesion.
• a select volume of contrast solution is again introduced into the manifold and delivered through the fluid delivery lumen to the vasculature immediately about the exit port or ports of the device and a post-treatment angiogram of the vasculature about the treated lesion is taken.
• the device and guide wire are then removed from the patient.
• the transition section may be located distal to an exit port that is in turn distal to the distal end of the balloon.
• the guide wire lumen in this example may further comprise a second exit port located proximal to the proximal end of the balloon, thus placing both exit ports in the area of larger diameter. The insertion of a guide wire through the guide wire lumen creates an area of increased resistance to flow at the portion of the lumen with the smaller diameter, directing the flow of contrast out of the exit ports.
• the guide wire lumen may be sized to optionally accept more than one guide wire to improve the pushability of the device.
• One method of using this embodiment is to insert a guide wire inside the catheter while the locking feature(s) are in the baseline state, advance the guide wire such that the distal tip of the guide wire is distal to the distal end of the catheter, and activate the locking feature(s) of the catheter to engage the two devices.
• the catheter may then be advanced in the distal direction by pulling on the distal end of the guide wire as previously described.
• the locking feature(s) may optionally be returned to the baseline state, disengaging the catheter and guide wire.
• the proximal end of the infusion lumen may be connected to a port that enables the infusion of liquids through the lumen and out the distal end and/or exit ports of the lumen.
• the liquids may comprise materials including, but not limited to contrast, saline, solutions of contrast and saline, solutions of therapeutic agents, combinations thereof, and the like.
• the support catheter may further comprise a second elongate member coaxially disposed within the first elongate member; the second elongate member comprising a proximal end, a distal end, and a lumen extending therethrough.
• the proximal end of the second elongate member may further be constrained to maintain a position at or proximal to the distal end of the first elongate member.
• the second elongate member may translate freely with respect to the first elongate member, and may optionally rotate freely with respect to the first elongate member.
• the first elongate member may be of a length such that the second elongate member may be positioned entirely within the first elongate member (i.e., the distal end of the second elongate member is aligned with the distal end of the first elongate member).
• the first and second elongate members may have one or more features to control the position of the distal end of the second elongate member with respect to the distal end of the first elongate member.
• Such feature(s) may include, but are not limited to detents, living hinges, key and keyhole designs, tapped holes, screws, set screws, valves, combinations thereof, and the like.
• the first elongate member may further comprise a window extending some distance along the length of the elongate member and a threaded hole.
• the second elongate member may further comprise a post extending radially outwardly away from the longitudinal axis of the support catheter and through the window of the first elongate member.
• the support catheter may further comprise a screw inserted into the tapped hole of the first elongate member. The position of the distal end of the second elongate member relative to the distal end of the first elongate member may be adjusted by advancing the post in the proximal or distal directions. When the desired position is located, the screw may be tightened to press against the second elongate member and fix the position of the second elongate member relative to the first elongate member.
• the first elongate member may further comprise markings that convey information about the location of the distal end of the second elongate member relative to the distal end of the first elongate member, e.g., using methods known in the art including, but not limited to etching, labeling, pad printing, molding, machining, combinations thereof, and the like. It should be evident to one of ordinary skill in the art that such markings may also convey information about the rotational position of the second elongate member with respect to the first elongate member.
• a support catheter in accordance with still another embodiment, includes a first elongate member with proximal and distal ends and a lumen extending there through.
• the support catheter further comprises an expandable elongate member with proximal and distal ends and a lumen extending there through.
• the proximal end of the expandable elongate member is joined to the distal end of the first elongate member such that the lumen of the first elongate member is in communication with the lumen of the expandable elongate member.
• the support catheter further comprises a distal segment with proximal and distal ends and a lumen extending there through. The proximal end of the distal segment is joined to the distal end of the expandable elongate member such that lumen of the expandable elongate member is in communication with the lumen of the distal segment.
• the expandable elongate member may comprise structures known in the art including, but not limited to, flexible membranes or tubing, metallic or polymeric braids, stents, combinations thereof, and the like. Furthermore, the expandable elongate member may exist in a baseline or active state. The annular diameter of the expandable elongate member in the baseline state is such that a guide wire may freely pass through the lumen of the expandable elongate member. When activated, the external diameter of the expandable elongate member increases. The expandable elongate member may reversibly transition between the active and baseline states.
• the presence of a guide wire within the lumen of the support catheter may reduce or impede flow of fluid out of the distal end of the guide wire.
• the internal pressure created by the introduction of fluid into the lumen of the support catheter may then expand the flexible membrane. Reducing the pressure in the lumen of the support catheter allows the flexible membrane of the expandable elongate member to return to its baseline annular and external diameters.
• the support catheter with expandable elongate member may be used to dilate a lesion.
• the guide wire is exchanged with another guide wire, such as a guide wire having a more atraumatic tip (e.g., a soft tip), while the support catheter is in position across the lesion.
• the support catheter may then be removed and the treatment catheter inserted over the guide wire and advanced to cross the lesion.
• a totally occluding lesion where the treatment catheter is unable to cross the totally occluding lesion after successful crossing of the guide wire.
• the treatment catheter may be replaced with another treatment device, for example, a smaller diameter balloon catheter having a smaller profile, which is then used to cross the lesion and pre-dilate the lesion to create a larger lumen opening.
• the treatment catheter is then reintroduced and advanced over the guide wire and across the lesion and the treatment is performed.
• a support catheter In this procedure, a guide wire is introduced and placed at or near the lesion followed by the support catheter with its expandable elongate member in the baseline state. The guide wire is advanced to cross the lesion followed by advancement of the support catheter across the lesion such that the expandable elongate member is positioned within or across the lesion. Fluid is injected into the lumen of the support catheter, increasing the internal pressure in the support catheter, stretching out the expandable elongate member and effectively dilating the lesion to increase the lumen and allow subsequent passage of a treatment catheter (e.g., a balloon angioplasty catheter, dilatation catheter, artherectomy catheter, etc.).
• a treatment catheter e.g., a balloon angioplasty catheter, dilatation catheter, artherectomy catheter, etc.
• Additional embodiments may include a treatment catheter (including those disclosed herein) and the expandable elongate member described herein.
• a typical support catheter is unable to cross the lesion after successful crossing of the guide wire
• other devices and/or methods may be used such as de- bulking or atherectomy devices (e.g., rotablator, laser, etc.) to remove or obliterate tissue to create a passage to ease placement of treatment devices.
• de- bulking or atherectomy devices e.g., rotablator, laser, etc.
• the use of these alternative devices and/or methods may be eliminated or avoided by providing a support catheter in this embodiment in combination with a guide wire that incorporate design features to lock or engage these two devices together and/or using the method described previously, e.g., where the devices move in unison as these devices are pulled from their distal side or distal end in order to cross the lesion.
• One of the advantages of the devices and methods described herein is the ability to perform selective angiography through the treatment catheter itself resulting in use of less contrast, thereby reducing the risk of nephropathy and decreasing physician and patient exposure to harmful radiation.
• the capability of the treatment catheter to conduct selective angiography may eliminate the need for a larger profile angiographic catheter such a guide catheter or sheath.
• Another advantage of a lower profile treatment device is a reduction in diameter of the sheath required to obtain access to the patient's vasculature, reducing the potential for complications related to access site closure and potentially eliminating the need for access site closure devices.
• This advantage is particularly apt during procedures that involve trans- pedal access.
• the position of the guide wire in the vasculature may be maintained during contrast injection, reducing procedure time as exchange maneuvers between the guide wire and contrast injection manifold are eliminated.
• fluids such as thrombolytics or other commonly used drugs (e.g., nitroglycerin, papaverine, heparin, tPa, etc.) may be achieved more effectively by using the fluid delivery lumen of the embodiments described herein.
• thrombolytics e.g., nitroglycerin, papaverine, heparin, tPa, etc.
• drugs e.g., nitroglycerin, papaverine, heparin, tPa, etc.
• blood may perfuse through the proximal and distal exit ports whereas conventional treatment devices may occlude blood flow.
• the reduced profile of the regroomed or folded expandable member may allow for improved contrast flow past the expandable member and subsequent improvement of the resulting angiographic images.
• the need for a separate support catheter may be eliminated, reducing procedure time and expense.
• FIG. IB depicts a plan view and cross-sectional views ( ⁇ '- ⁇ ', ⁇ '- ⁇ ') of the catheter of FIG. 1A with a guide wire placed in the guide wire lumen.
• FIG. 2A depicts a plan view and cross-sectional views (A-A, B-B) of a second exemplary embodiment of a catheter comprising multiple independent lumens wherein the guide wire lumen is common with the lumen used for infusion of fluids.
• FIG. 2B depicts a plan view and cross-sectional views ( ⁇ '- ⁇ ', ⁇ '- ⁇ ') of the catheter of FIG. 2A with a guide wire placed in the guide wire lumen.
• FIG. 3B depicts a plan view and cross-sectional views ( ⁇ '- ⁇ ', ⁇ '- ⁇ ') of the catheter of FIG. 3B with a guide wire placed in the guide wire lumen.
• FIGS. 4A-4E depict plan views of an exemplary embodiment of a reinforced guide wire and several iterations of a removable jacket taper that may be secured over the guide wire.
• FIGS. 8A-8F depict cross-sections of an artery showing schematics of the steps involved in an alternative method for treating a peripheral arterial lesion.
• FIG. 9 depicts a plan view of an exemplary embodiment of a support catheter.
• FIGS. 10A-10B depict plan views of another exemplary embodiment of a support catheter including a telescoping segment.
• the manifold 106 further includes a fluid injection port 107, inflation port 108, and guide wire insertion port 109.
• the proximal end of the fluid delivery lumen 102 is in communication with the fluid injection port 107.
• the proximal end of the inflation lumen 103 is in communication with the inflation port 108, and the proximal end of the guide wire lumen 104 is in communication with the guide wire insertion port 109.
• the distal end of the inflation lumen 103 is in communication with the interior of expandable member 110.
• Exit port 205 may be a singular opening or a collection of multiple openings located at any point along the length and circumference of the fluid delivery/guide wire lumen 203, or a single port located at the distal tip of the elongate member 201.
• the catheter 200 may include one or more marker bands or visual indicators (not shown) placed along the length of the elongate member 201 (e.g., a radiopaque marker band positioned inside or within the inflatable infusion element 211 and/or at least one printed marker in the proximal side of the elongate member 201).
• the manifold 206 further includes a fluid injection port 207, an inflation port 208, a guide wire insertion port 209, and a gasket 210. While the gasket 210 is depicted as an o-ring in FIGS. 2A and 2B, it should be clear to one of skill in the art that any feature for creating a seal at guide wire insertion port 209 may suffice, including but not limited to a Touhy-Borst valve, a septum, a valve fabricated by multiple layers of elastomeric materials, an iris, combination thereof, and the like (not shown).
• the proximal end of the fluid delivery/guide wire lumen 203 is in communication with the fluid injection port 207 and the guide wire insertion port 209.
• the proximal end of the inflation lumen 202 is in communication with the inflation port 208.
• the distal end of the inflation lumen 202 is in communication with the interior of expandable member 211.
• the insertion of the guide wire 212 into region 203" may significantly reduce the cross sectional area of the fluid delivery/guide wire lumen 203 available to flow as compared to the size of the exit port 205, thus directing the flow of fluid preferentially out of the exit port 205. While the outer diameter of the guide wire 212 and the smaller inner diameter 203" of the fluid delivery/guide wire lumen 203 are shown to be in close approximation in FIG.
• Both inflatable inflation elements 213 and 214 include at least one infusion exit port or opening 215 that aims and projects infused fluid along the direction of the blood vessel or lumen.
• the catheter 200 may include at least one marker band or visual indicator (not shown) placed along the length of the elongate member 201 (e.g., a radiopaque marker band positioned inside or within the inflatable infusion elements 213 and 214 and /or at least one printed marker located along the proximal side of the elongate member 201, not shown).
• the inflatable infusion elements 213 and 214 may be fabricated from compliant and/or non-compliant, reinforced and/or unreinforced plastics, elastomers and/or composites thereof, including but not limited to: polyurethane, PEBAX, PET, nylon, PE, silicone rubber, C-flex and the like.
• the inflatable infusion elements 213 and 214 may be fabricated using processes including but not limited to blow molding, dipping, spraying, injection molding, extruding and the like.
• the transit ports 223, 223' and the directional infusion exit ports 215 may be formed using processes including but not limited to drilling, laser cutting, die punching, skiving, and the like.
• the exit port(s) 215 may be oriented or otherwise configured such that the fluid jet is ejected from the exit port(s) 215 may be aimed proximally or distally or any combination thereof, e.g., by positioning the directional infusion exit port 215 on the appropriate sides of the inflatable infusion elements 213 and 214.
• the directional infusion port 215 may also be complimented or replaced by providing an opening located at the interface between the inflatable infusion elements 213 and/or 214 and the outer surface of the elongate member 201.
• the inflatable infusion elements 214 and 213 may expand to a diameter configured to engage a surrounding wall of a vessel or lumen, e.g., to cause occlusion of the vessel or lumen.
• the expanded diameter of the inflatable infusion elements 213 and 214 may be reduced to obviate vessel or lumen occlusion to thereby maintain blood perfusion.
• the catheter 200 may include only one inflatable infusion element (not shown).
• the catheter 200 may include only inflatable infusion element 213 and expandable member 211; or may comprise only inflatable infusion element 214 and expandable member 211.
• the catheter 200 may include no inflatable infusion elements 214 and/or 213 such that infused fluids may exit directly to the bloodstream or vessel or lumen via the transit ports 223' and/or 223.
• the shaft member 219 includes at least one transit port 221 in a side wall thereof that communicates between the lumen 220 and the interior of the inflatable infusion element 216 such that infused fluid may exit to the bloodstream or vessel or lumen via the directional infusion exit port(s) 215.
• the infusion flow rate and pressure build up within the inflatable infusion element 216 may be controlled using the constructions and/or methods described previously.
• FIGS. 3D-3G Alternative embodiments to catheter 200' are shown in FIGS. 3D-3G, which include cross-sectional views of catheters 200" and 200" '.
• Each of these catheters 200" 200"' include at least one directional infusion exit opening 237 that directs infusion of fluid proximally and an inflatable infusion element 227 that may partially or totally occlude a vessel or artery during fluid infusion or injection.
• the inflatable infusion element 227 may be a balloon fabricated from compliant and/or non-compliant, reinforced and/or
• An inflatable infusion element 227 is attached to a distal portion of the elongate member 226 such that a wall of the elongate member 226 defining the distal end of the inflation lumen 232 terminates and is attached to a proximal leg 235 of the inflatable infusion element 227.
• the inflation lumen 233 is in direct communication with the interior of the inflatable infusion element 227.
• the guide wire lumen 233 extends past the distal leg 236 of the inflatable infusion element 227 such that a distal leg 236 of the inflatable infusion element 227 is attached to the elongate member 226 adjacent a tip thereof 229 including an outlet port for the guide wire lumen 233.
• the elongate member 226 includes at least one transit port 234 disposed at a distal section of the inflation lumen 233 proximal to the proximal leg 235 of the inflatable infusion element 227.
• the transit port 234 may be formed using processes including but not limited to drilling, laser cutting, die punching, skiving, and the like.
• the extended proximal leg 235 may not be attached at all to the elongate member 226, e.g., over or proximal to the transit port 234, such that the extended proximal leg 235 may expand to create a directional infusion exit opening when exposed to pressure within the infusion lumen 233 beyond a predetermined threshold.
• the compliant tubular member 228 may be omitted from the catheter 200" of FIGS. 3D-3E, leaving the transit port 234 exposed to the space or environment external to the catheter 200".
• valve mechanism (not shown) or other form of shielding or covering associated with the transit port 234, in place of the compliant tubular member 228.
• This valve mechanism may provide one-way directionality of fluid flow and/or may open at a predefined infusion pressure, thus having similar function as the compliant tubular member 228.
• the location where the fluid exits from the catheter 200"' may be located distal of the inflatable infusion element 227expandable member, e.g., to direct the fluid infusion in a distal direction, i.e., distally beyond the distal tip of the elongate member 239 (not shown).
• the distal tip 303 of the guide wire 301 may be shaped in an atraumatic geometry, such as a hemisphere, dome, or the like.
• the surface of the guide wire 301 may be coated (not shown) with hydrophilic or hydrophobic and/or antithrombogenic materials, plated with gold or platinum, and/or other otherwise modified to obtain properties that differ from those of the underlying material.
• the removable jacket 302 comprises proximal and distal ends and at least one lumen therethrough, and is arranged coaxially about the guide wire 301.
• the distal region 304 of the removable jacket 302 may be tapered as shown in FIG. 4A.
• the removable jacket 302 may be radially symmetric or radially asymmetric.
• the removable jacket 302 may be formed from materials known in the art including, but not limited, to stainless steel, platinum, nitinol, Pebax, nylon, Delrin, polymethymethacrylate,
• the shape of the distal region 304 may be convex (e.g., as shown in FIG. 4B), concave (e.g., as shown in FIG. 4C), stepped or blunt (e.g., as shown in FIG. 4D), or some combination thereof (e.g., as shown in FIG. 4E). It should be clear to one of skill in the art that other alternative shapes for the distal region 304 may be considered and fabricated.
• the removable jacket 302 may have a different or similar stiffness than guide wire 301. Moreover, the removable jacket 302 may comprise of one stiffness along its length or may have sections of different stiffnesses along its length. The proximal end of the removable jacket 302 may be joined to a handle 305, e.g., using one or more features known in the art including, but not limited to, adhesive bonding, soldering, welding, ultrasonic welding, press fitting, threading/tapping, snap fitting, combinations thereof, and the like.
• the handle 305 may be fabricated using methods known in the art including machining, molding, forging, and the like out of materials known in the art including, but not limited to, stainless steel, titanium, polycarbonate, polymethylmethacrylate, Pebax, ABS, delrin, nylon, polyurethane, and the like.
• the handle 305 and/or removable jacket 302 may also include a sculpted, grooved, scalloped, turned, or otherwise featured outer surface, e.g., to ease holding and/or handling.

Landscapes

• Health & Medical Sciences (AREA)
• Life Sciences & Earth Sciences (AREA)
• Heart & Thoracic Surgery (AREA)
• Biomedical Technology (AREA)
• Engineering & Computer Science (AREA)
• Anesthesiology (AREA)
• Pulmonology (AREA)
• Biophysics (AREA)
• Hematology (AREA)
• Animal Behavior & Ethology (AREA)
• General Health & Medical Sciences (AREA)
• Public Health (AREA)
• Veterinary Medicine (AREA)
• Child & Adolescent Psychology (AREA)
• Media Introduction/Drainage Providing Device (AREA)

Priority Applications (6)

Applications Claiming Priority (4)

Related Child Applications (1)

Publications (1)

Family

ID=50184471

Family Applications (1)

Country Status (7)

Cited By (10)

Families Citing this family (34)

Citations (8)

Family Cites Families (12)

• 2013
  • 2013-08-30 WO PCT/US2013/057733 patent/WO2014036530A1/en not_active Ceased
  • 2013-08-30 CN CN201380056202.1A patent/CN104755126A/zh active Pending
  • 2013-08-30 AU AU2013308439A patent/AU2013308439A1/en not_active Abandoned
  • 2013-08-30 JP JP2015530129A patent/JP2015526259A/ja active Pending
  • 2013-08-30 EP EP13833340.6A patent/EP2890440A4/en not_active Withdrawn
  • 2013-08-30 CA CA2922640A patent/CA2922640A1/en not_active Abandoned
• 2015
  • 2015-02-27 US US14/634,694 patent/US20150174379A1/en not_active Abandoned

Patent Citations (8)

Non-Patent Citations (1)

Also Published As

Similar Documents

Legal Events